Sino Biological, Tencent AI protein design
Analysis based on 13 articles · First reported May 28, 2026 · Last updated May 28, 2026
The collaboration between Sino Biological>>> and Tencent>>> in protein engineering, published in Tata Communications>>>, could positively impact the biotechnology sector by demonstrating advanced applications of Artificial intelligence. This event may lead to increased investor confidence in companies leveraging AI for scientific research, potentially boosting Sino Biological>>>'s stock on the Shenzhen Stock Exchange>>> due to enhanced visibility and validation of its technology.
Sino Biological announced that its gene synthesis and cell-free protein expression workflow, including the XPressMAX™ Cell-Free Protein Synthesis Kit, was used in a study by Tencent AI for Life Sciences Lab. The research, published in Tata Communications, focused on rapidly validating AI-designed proteins with improved activity, stability, and multifunctionality. The study introduced an Ontology Reinforcement Iteration (ORI) framework, integrating protein ontology with reinforcement learning from wet-lab feedback to optimize protein sequences. This workflow enabled the engineering of enzymes with significantly higher activity and thermostability, bridging the gap between AI protein design and experimental validation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard